Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666781 | PMC |
http://dx.doi.org/10.1128/JCM.03341-12 | DOI Listing |
Adv Intell Syst
September 2024
Northwestern University, Chicago, IL.
Capsule networks promise significant benefits over convolutional networks by storing stronger internal representations, and routing information based on the agreement between intermediate representations' projections. Despite this, their success has been limited to small-scale classification datasets due to their computationally expensive nature. Though memory efficient, convolutional capsules impose geometric constraints that fundamentally limit the ability of capsules to model the pose/deformation of objects.
View Article and Find Full Text PDFInt J Mol Sci
November 2024
UOC Laboratory of Clinical Medicine with Specialized Areas, IRCCS MultiMedica Hospital, 20138 Milan, Italy.
Heterophile antibodies, which can arise from infections, autoimmune disorders, or exposure to animal antigens, can interfere with immunoassays. These antibodies can cross-react with the test reagents used in troponin assays, causing a false elevation in troponin levels. The paper describes a case of a 37-year-old male drug abuser admitted to the emergency room with chest pain.
View Article and Find Full Text PDFJ Autism Dev Disord
September 2024
Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
The COVID-19 pandemic revealed the need to develop the field of remote assessment for autism spectrum disorders (ASD). The purpose of the study was to evaluate an online assessment protocol that includes the Brief Observation of Symptoms of Autism (BOSA). The online protocol consisting of BOSA and the Autism Diagnostic Interview-Revised (ADI-R) was administered by experienced examiners to 29 children with suspected ASD.
View Article and Find Full Text PDFObstet Gynecol Surv
September 2024
Professor of Obstetrics and Gynecology, Maternal-Fetal Medicine, Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Duke University Health System, Durham, NC.
Importance: With advances in prenatal cell-free DNA (cfDNA) technology, the information available with cfDNA continues to expand beyond the common fetal aneuploidies such as trisomies 21, 18, and 13. Due to the admixture of maternal and fetal/placental DNA, prenatal cfDNA remains a screening test with the possibility of false-positive and false-negative results.
Objective: This review aims to summarize unusual incidental maternal and fetal genomic abnormalities detectable by cfDNA and to provide anticipatory guidance regarding management.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!